AKT1 and Hyperglycemia: TXM-CB3 also reversed in insulin- and OS-induced phosphorylation of ERK1/2 and AKT/PKB in FAO hepatoma cells, further supporting its role in modulating OS-induced signaling pathways associated with hyperglycemia and metabolic disfunction.